These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 20024855)

  • 1. [Pulmonary embolism as a first manifestation of synchronous occurrence of two neoplasms].
    Elikowski W; Lewandowska M; Małek M; Krokowicz P; Piotrowska-Stelmaszyk G; Zawilska K
    Kardiol Pol; 2009 Nov; 67(11):1262-6; discussion 1267. PubMed ID: 20024855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective prophylaxis of thromboembolic complications with low molecular weight heparin in relapsed multiple myeloma patients treated with lenalidomide and dexamethasone.
    Klein U; Kosely F; Hillengass J; Hundemer M; Schmitt S; Neben K; Moehler T; Hegenbart U; Ho AD; Goldschmidt H
    Ann Hematol; 2009 Jan; 88(1):67-71. PubMed ID: 18668241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy.
    Minnema MC; Breitkreutz I; Auwerda JJ; van der Holt B; Cremer FW; van Marion AM; Westveer PH; Sonneveld P; Goldschmidt H; Lokhorst HM
    Leukemia; 2004 Dec; 18(12):2044-6. PubMed ID: 15470485
    [No Abstract]   [Full Text] [Related]  

  • 4. [Deep vein thrombosis and pulmonary embolism in a patient with multiple myeloma treated with thalidomide and dexamethasone].
    Miyazawa Y; Irisawa H; Uchiumi H; Saitoh T; Handa H; Matsushima T; Tsukamoto N; Karasawa M; Murakami H; Nojima Y
    Rinsho Ketsueki; 2006 Jul; 47(7):656-60. PubMed ID: 16910577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.
    Huston A; Brown J; Roodman GD
    Exp Hematol; 2006 Dec; 34(12):1616. PubMed ID: 17157156
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypercoagulable states in patients with multiple myeloma can affect the thalidomide-associated venous thromboembolism.
    Talamo GP; Ibrahim S; Claxton D; Tricot GJ; Fink LM; Zangari M
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):337-9. PubMed ID: 19367157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy.
    Musallam KM; Dahdaleh FS; Shamseddine AI; Taher AT
    Thromb Res; 2009 Mar; 123(5):679-86. PubMed ID: 18992924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avascular necrosis of femoral and/or humeral heads in multiple myeloma: results of a prospective study of patients treated with dexamethasone-based regimens and high-dose chemotherapy.
    Talamo G; Angtuaco E; Walker RC; Dong L; Miceli MH; Zangari M; Tricot G; Barlogie B; Anaissie E
    J Clin Oncol; 2005 Aug; 23(22):5217-23. PubMed ID: 15955903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticoagulation regimens for thalidomide and lenalidomide.
    Zangari M
    Clin Adv Hematol Oncol; 2006 Sep; 4(9):658-9. PubMed ID: 17099621
    [No Abstract]   [Full Text] [Related]  

  • 10. Thalidomide and dexamethasone therapy of myeloma in a patient with previously untreated B-chronic lymphocytic leukemia.
    Barton JC
    Am J Hematol; 2003 Nov; 74(3):205-7. PubMed ID: 14587053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venous thromboembolism during pregnancy or postpartum: findings from the RIETE Registry.
    Blanco-Molina A; Trujillo-Santos J; Criado J; Lopez L; Lecumberri R; Gutierrez R; Monreal M;
    Thromb Haemost; 2007 Feb; 97(2):186-90. PubMed ID: 17264945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboembolism risk reduction in multiple myeloma patients treated with immunomodulatory drug combinations.
    Hussein MA
    Thromb Haemost; 2006 Jun; 95(6):924-30. PubMed ID: 16732369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lenalidomide in combination with dexamethasone for the treatment of multiple myeloma after one prior therapy.
    Hazarika M; Rock E; Williams G; Dagher R; Sridhara R; Booth B; Farrell A; Justice R; Pazdur R
    Oncologist; 2008 Oct; 13(10):1120-7. PubMed ID: 18922829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metachronous Wilms tumor associated with pulmonary embolism: how can we detect these cases early? A case report and literature review.
    Ahmed R; al-Salti W; Raafat F; Morland B
    Pediatr Hematol Oncol; 2003; 20(1):55-63. PubMed ID: 12687754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase III clinical trial of thalidomide plus dexamethasone compared with dexamethasone alone in newly diagnosed multiple myeloma: a clinical trial coordinated by the Eastern Cooperative Oncology Group.
    Rajkumar SV; Blood E; Vesole D; Fonseca R; Greipp PR;
    J Clin Oncol; 2006 Jan; 24(3):431-6. PubMed ID: 16365178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of multiple myeloma: 2009 update.
    Prescrire Int; 2009 Dec; 18(104):263-6. PubMed ID: 20025098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism and cancer: risks and outcomes.
    Lee AY; Levine MN
    Circulation; 2003 Jun; 107(23 Suppl 1):I17-21. PubMed ID: 12814981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide-dexamethasone as primary therapy for advanced multiple myeloma.
    Wang M; Weber DM; Delasalle K; Alexanian R
    Am J Hematol; 2005 Jul; 79(3):194-7. PubMed ID: 15981221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment options and considerations for the newly diagnosed myeloma patient.
    Rajkumar VS;
    Oncology (Williston Park); 2005 Sep; 19(10):1260, 1262, 1267 passim. PubMed ID: 16285223
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombosis in multiple myeloma.
    Zangari M; Elice F; Fink L; Tricot G
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):307-15. PubMed ID: 17338651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.